
- Telehealth Visits
- Insurance plan information

Ammar Joudeh, MD
He | Him | HisGynecologic Oncology • Gynecologic Medical Oncology- Telehealth Visits
- Insurance plan information



Ammar Joudeh, MD
He | Him | HisGynecologic Oncology • Gynecologic Medical Oncology- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Ammar Joudeh is an obstetrician and gynecologist who specializes in minimally invasive gynecologic surgery and in-office procedures. His care addresses abnormal uterine bleeding, fibroids, ovarian cysts, sexual health and family planning, contraception, vulvar conditions, pelvic pain, endometriosis, menopause and abnormal Pap tests. He has special expertise in the medical and surgical treatment options for gynecologic conditions in cancer survivors and other patients at elevated risk of gynecologic cancers. He also provides preconception, prenatal, labor and delivery and postpartum care. Centering care on each patient's needs, values and preferences, he embraces shared decision-making and individually tailored treatment plans.
Joudeh earned his medical degree at UCSF and completed a residency in obstetrics and gynecology at the University of California, San Diego. Prior to medical school, he conducted research on maternal health, infectious disease and educational programs in Zambia, India and the Philippines. His academic interests include improving the quality of obstetric and gynecologic care, as well as teaching medical students and residents.
Outside of work, Joudeh enjoys yoga, surfing, skiing, reading and music.
Education & training
Residency
- Obstetrics & Gynecology, University of California - San Diego
Degree
- MD, UCSF School of Medicine
My expertise
Specialties
- Gynecologic Oncology
- Gynecologic Medical Oncology
- Obstetrics and Gynecology
Locations
My research
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.